AI assistant
Sending…
Immunome Inc. — Director's Dealing 2021
May 27, 2021
32238_dirs_2021-05-26_22370681-f3c4-451b-9aa7-878ec214971b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2021-05-24
Reporting Person: LAMATTINA JOHN L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-24 | Common Stock | P | 338 | $18.44 | Acquired | 46726 | Direct |
| 2021-05-24 | Common Stock | P | 5102 | $18.58 | Acquired | 51828 | Direct |
More from Immunome Inc.
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2025
Dec 31
Director's Dealing
2025
Dec 23
Major Shareholding Notification
2025
Dec 23